Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 3
2016 1
2017 1
2018 2
2019 3
2020 3
2021 3
2022 7
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Choroidal Vascularity in Non-arteritic Anterior Ischaemic Optic Neuropathy.
Guduru A, Abdul Rasheed M, Goud A, Ashik M, Kumar VK, Chhablani J, Badakere A, Kekunnaya R, Patil-Chhablani P. Guduru A, et al. Among authors: abdul rasheed m. Neuroophthalmology. 2019 Feb 1;43(5):305-309. doi: 10.1080/01658107.2019.1566384. eCollection 2019 Nov. Neuroophthalmology. 2019. PMID: 31741674 Free PMC article.
Racial Differences in Choroidal Vascularity Index in Healthy Patients: Novel Insights.
Moir J, Kaufmann G, Rodriguez SH, Nourian N, Abdul Rasheed M, Vupparaboina KK, Chhablani J, Skondra D. Moir J, et al. Among authors: abdul rasheed m. Ophthalmic Surg Lasers Imaging Retina. 2024 Jan;55(1):30-38. doi: 10.3928/23258160-20231113-01. Epub 2024 Jan 1. Ophthalmic Surg Lasers Imaging Retina. 2024. PMID: 38189798
1-[2-(1-Cyclobutylpiperidin-4-yloxy)-6,7-dihydro-4H-thiazolo[5,4-c]pyridin-5-yl]propan-1-one: a Histamine H3 Receptor Inverse Agonist with Efficacy in Animal Models of Cognition.
Shinde AK, Badange RK, Reballi V, Achanta PK, Bojja K, Manchineella S, Rao Muddana N, Subramanian R, Choudary Palacharla R, Benade V, Jayarajan P, Thentu JB, Lingavarapu BB, Yarra S, Kagita N, Rao Doguparthi M, Mohammed AR, Nirogi R. Shinde AK, et al. Among authors: mohammed ar. ChemMedChem. 2022 Feb 4;17(3):e202100583. doi: 10.1002/cmdc.202100583. Epub 2021 Nov 18. ChemMedChem. 2022. PMID: 34761873
Potential beneficial effects of masupirdine (SUVN-502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analyses.
Nirogi R, Jayarajan P, Benade V, Shinde A, Goyal VK, Jetta S, Ravula J, Abraham R, Grandhi VR, Subramanian R, Pandey SK, Badange RK, Mohammed AR, Jasti V, Ballard C, Cummings J. Nirogi R, et al. Among authors: mohammed ar. Int J Geriatr Psychiatry. 2022 Oct;37(10):10.1002/gps.5813. doi: 10.1002/gps.5813. Int J Geriatr Psychiatry. 2022. PMID: 36168659 Free PMC article.
Discovery and Preclinical Characterization of Usmarapride (SUVN-D4010): A Potent, Selective 5-HT4 Receptor Partial Agonist for the Treatment of Cognitive Deficits Associated with Alzheimer's Disease.
Nirogi R, Mohammed AR, Shinde AK, Gagginapally SR, Kancharla DM, Ravella SR, Bogaraju N, Middekadi VR, Subramanian R, Palacharla RC, Benade V, Muddana N, Abraham R, Medapati RB, Thentu JB, Mekala VR, Petlu S, Lingavarapu BB, Yarra S, Kagita N, Goyal VK, Pandey SK, Jasti V. Nirogi R, et al. Among authors: mohammed ar. J Med Chem. 2021 Aug 12;64(15):10641-10665. doi: 10.1021/acs.jmedchem.1c00703. Epub 2021 Jul 12. J Med Chem. 2021. PMID: 34251799
Ropanicant (SUVN-911), an α4β2 nicotinic acetylcholine receptor antagonist intended for the treatment of depressive disorders: pharmacological, behavioral, and neurochemical characterization.
Nirogi R, Abraham R, Jayarajan P, Goura V, Kallepalli R, Medapati RB, Tadiparthi J, Goyal VK, Pandey SK, Subramanian R, Petlu S, Thentu JB, Palacharla VRC, Gagginapally SR, Mohammed AR, Jasti V. Nirogi R, et al. Among authors: mohammed ar. Psychopharmacology (Berl). 2022 Jul;239(7):2215-2232. doi: 10.1007/s00213-022-06108-6. Epub 2022 Mar 17. Psychopharmacology (Berl). 2022. PMID: 35298691
25 results